MedPath

Rocuronium Effective Dose for Laparoscopic Cholecystectomy

Phase 3
Completed
Conditions
Muscle Relaxation
Interventions
Registration Number
NCT03043157
Lead Sponsor
Brasilia University Hospital
Brief Summary

This is an adaptative study where each participant's rocuronium dose will depend on the previous patient's response, being higher if it was not enough and lower if it was more than enough.

Detailed Description

Rocuronium is one of the most used neuromuscular blockers to help intubation and to relax abdominal wall for laparoscopic surgery.

Rocuronium intubation dose can be enough for intubation but not last enough for excellent laparoscopic conditions. There is little variation in time from anesthesia induction to the end of the laparoscopy for cholecystectomy and avoiding excess rocuronium dose can help providing excellent conditions and fast track extubation.

Dixon's up-and-down method will guide this dose-finding study for the ED50.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • general anesthesia
Exclusion Criteria
  • deny participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Dose-finding grouprocuroniumThe first patient will receive rocuronium 0,6mg/kg. After that, every patient's dose will depend on the outcome of the previous patient. It will go up 0,1mg/kg if the laparoscopic conditions were not excellent or go down 0,1mg/kg otherwise.
Primary Outcome Measures
NameTimeMethod
Excellent laparoscopic conditions30 minutes

Subjective laparoscopic conditions for surgery, assessed by the main surgeon, as excellent or not

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital das Forças armadas

🇧🇷

Brasilia, Distrito Federal, Brazil

© Copyright 2025. All Rights Reserved by MedPath